Personalized mRNA Vaccine May Delay Pancreatic Cancer Recurrence
According to a phase I clinical trial published in Nature, a novel personalized RNA neoantigen vaccine combined with immunotherapy and chemotherapy has demonstrated significant potential to delay pancreatic cancer. Background…